Beginner view — everything explained simply.
CJC-1295 + Ipamorelin
Two peptides meant to prompt the body to make more of its own growth hormone — popular in the scene, but not approved
In 10 seconds
CJC-1295 and Ipamorelin are two lab-made peptides that are often named together. The idea behind it: they're meant to prompt the body to release more of its own growth hormone. But both are research peptides without approval for humans and are banned in sport.
What is it, really?
Your body releases growth hormone in small bursts — almost like a bouncer who only opens the door at certain times. These two peptides act at different points of this system: Ipamorelin signals the pituitary gland to release more hormone, and CJC-1295 strengthens this signal. Both officially count as so-called research peptides — meant only for lab purposes, not as a tested medicine.
In pictures
Structure
A chain built from amino acids
Target area
Growth-hormone & IGF-1 axis (research)
Evidence
Animal studies
Human studies
Mechanism well studied, but barely any reliable safety data in humans
What fans report
Claims — not proof
- Some in the fitness scene claim that, via more of the body's own growth hormone, the combo helps with muscle building and fat loss (anecdotal reports, not proven facts)
- In forums it's linked to better recovery and deeper sleep (purely anecdotal claims)
- Fans assume the two complement each other because they're supposed to act at different points of the hormone axis
The reality check
What the facts say
- Both are approved as a medicine for humans nowhere — neither in the EU nor in the USA
- Banned in sport: GH secretagogues and GHRH analogs are on the WADA prohibited list (category S2)
- It's an intervention in the hormone axis — that can, for example, affect blood sugar and insulin action, and the long-term safety of the combination isn't settled
- Grey-market goods: purity, identity, and sterility are unsecured, and the DAC/non-DAC variants are easily confused — which can strongly change the effect profile
- In 2025 an injectable CJC-1295 batch was recalled for lack of sterility (FDA Class II recall); the FDA also warns of immune reactions up to anaphylaxis
Risk assessment
It's an unapproved intervention in the hormone axis, plus there are real grey-market dangers like a sterility recall and FDA warnings of severe immune reactions up to anaphylaxis.
Legal status: Not approved for humans
Bottom line
Exciting for research on the growth-hormone axis — but for applying it to your own body there's neither approval nor enough safety. That belongs in a doctor's hands, not in self-experiment.
No buying · No dosing · Just knowledge
This page informs — it is no substitute for medical advice. If this topic affects you, talk to a doctor.
Why safety matters